Jul. 30 at 1:47 PM
$MDT people of Medtronic who love biotech space -
$NVNO is the next big winner - FDA approval expected August (4 out of 5 PMA chapters already approved, last chapter is clinical data which was excellent), breakthrough device designation by the FDA, first surgical treatment for deep Chronic Venous Insufficiency (which is what Trump was diagnosed with couple weeks ago). 90 mill market cap with 40 mill cash on hand. It’s a no brainer and should easily be 300 mill market cap after approval.